Aroch Itamar, Keidar Ido, Himelstein Anat, Schechter Miri, Shamir Merav Hagar, Segev Gilad
Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, 76100, Israel.
J Feline Med Surg. 2010 Jun;12(6):466-75. doi: 10.1016/j.jfms.2010.01.010. Epub 2010 Mar 16.
In veterinary medicine, serum creatine-kinase (CK) activity is mostly used to assess skeletal muscle damage. This retrospective study aimed to evaluate the prevalence of increased CK activity in a large, ill-cat population and to characterise associated diseases, clinical and laboratory findings and its prognostic value. Cats with a complete serum biochemistry analysis were consecutively enrolled, divided into two CK activity-based groups (within and above reference interval) and compared. The study included 601 cats. Median serum CK was 402 U/l (range 16-506870). Increased CK (>250 U/l) was observed in 364 (60%) cats, and>30-fold its upper reference limit in 43 (7%). Cats with increased CK had greater (P < or = 0.05) body weight, and were more likely to have a history of collapse, dyspnoea, abnormal lung sounds, cyanosis, shock and paraplegia, higher median serum alanine aminotransferase, aspartate aminotransferase and lactate dehydrogenase activities and total bilirubin and triglyceride concentrations, but lower, median total protein, albumin, globulin and cholesterol concentrations and proportion of anorexia than cats with normal CK. Cardiac diseases, trauma, bite wounds, systemic bacterial infections, prior anaesthesia and intramuscular injections were more common (P < or = 0.05) in cats with increased compared to normal CK activity. The hospitalisation period was longer (P=0.007) and treatment cost and mortality were higher (P<0.005) in cats with increased CK activity. However, CK activity was an inaccurate outcome predictor (area under the receiver operator characteristics curve 0.58). Increased CK activity is very common in ill cats.
在兽医学中,血清肌酸激酶(CK)活性主要用于评估骨骼肌损伤。这项回顾性研究旨在评估大量患病猫群体中CK活性升高的患病率,并对相关疾病、临床和实验室检查结果及其预后价值进行特征描述。连续纳入进行了完整血清生化分析的猫,将其分为基于CK活性的两组(参考区间内和参考区间以上)并进行比较。该研究共纳入601只猫。血清CK中位数为402 U/l(范围16 - 506870)。364只(60%)猫的CK升高(>250 U/l),43只(7%)猫的CK超过其参考上限的30倍。CK升高的猫体重更大(P≤0.05),更可能有虚脱、呼吸困难、肺部异常声音、发绀、休克和截瘫病史,血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶和乳酸脱氢酶活性以及总胆红素和甘油三酯浓度的中位数更高,但总蛋白、白蛋白、球蛋白和胆固醇浓度的中位数以及厌食比例低于CK正常的猫。与CK活性正常的猫相比,心脏病、创伤、咬伤、全身性细菌感染、既往麻醉和肌肉注射在CK升高的猫中更常见(P≤0.05)。CK活性升高的猫住院时间更长(P = 0.007),治疗费用和死亡率更高(P<0.005)。然而,CK活性是一个不准确的预后预测指标(受试者操作特征曲线下面积为0.58)。CK活性升高在患病猫中非常常见。